Trials / Sponsors / Kyoto Breast Cancer Research Network
Kyoto Breast Cancer Research Network
Academic / Other · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Breast Cancer Female, Hormone Receptor Positive Malignant Neoplasm of Breast | Phase 3 | 2019-07-16 |
| Completed | Anti PD-1 Antibody With Radiation Therapy in Patients With HER2-negative Metastatic Breast Cancer Breast Cancer | Phase 1 / Phase 2 | 2017-06-22 |
| Terminated | Anti PD-L1 Antibody + Anti CTLA-4 Antibody in Combination With Hormone Therapy in Patients With Hormone Recept Breast Cancer | Phase 2 | 2017-06-22 |